source
- FDA grants accelerated approval to Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has granted accelerated approval to Trutakna (formerly known as atacicept) from Vera Therapeutics for adult patients with IgA nephropathy, a chronic kidney disease that can progress to rena…
- Vertex to buy Crinetics for $10 billion, expanding into endocrine disease drugsVertex announced an agreement to acquire Crinetics Pharmaceuticals for $10 billion in cash, paying $85 per share. The purchase brings two recently launched drugs for a rare hormonal disorder into…